MW 500.6 Da, Purity >98%. Potent and selective small-molecule inhibitor of Wee1 kinase. Inhibits Wee1 (IC50 = 5.2 nM) in cell-free assays. Inhibits phosphorylation of CDC2 at Tyr15 (CDC2Y15), a direct substrate of Wee1 kinase in cell-based assays. Acts synergistically with gemcitabine in tumor cells. In a panel of 223 kinases, only 8 were inhibited >80% by 1μM MK-1775.
955365-80-7
> 98%
Solid
500.6 Da
C27H32N8O2
24856436
Synthetic
2310026J05Rik, 2610005A10Rik, 2610017K16Rik, 5033405D03Rik, ABL, ABL proto oncogene 1 non receptor tyrosine kinase, ABL1_HUMAN, ADCK1_HUMAN, ADK_HUMAN, AI255373, AI987814, AK, Abelson murine leukemia viral oncogene homolog 1, Abelson tyrosine protein kinase 1, Adenosine 5''-phosphotransferase, Adenosine kinase, Auxilin 2, BCR/ABL FUSION GENE, INCLUDED, BCR/FGFR1 FUSION GENE, INCLUDED, BCR/FGFR1 chimera protein, BCR/PDGFRA FUSION GENE, INCLUDED, BCR1, BCR_HUMAN, BOS_11212, Bcr/c abl oncogene protein, Breakpoint cluster region, Breakpoint cluster region protein, CDK16_HUMAN, CK II, CK II alpha', CK2A2, CML, CSK22_HUMAN, Casein kinase 2 alpha prime polypeptide, Casein kinase II alpha' chain, Casein kinase II subunit alpha', Cell cycle regulated protein kinase, Cell division protein kinase 16, Cellular Yes 1 protein, Cyclin-G-associated kinase, Cyclin-dependent kinase 16, D22S11, D22S662, DKFZp547K1610, DKFZp686I18166, DNAJ26, DNAJC26, Dual specificity mitogen-activated protein kinase kinase 4, EC 2.7.10.2, EC 2.7.11.1, EC 2.7.11.25, EPH receptor B6, EPHB6_HUMAN, Ephrin type B receptor 6 precursor, Ephrin type-B receptor 6, FGFR1/BCR chimera protein, FLJ11330, FLJ16446, FLJ16629, FLJ20093, FLJ39600, FLJ40395, FLJ43934, FTDALS4, GAK protein, GAK_HUMAN, HEP, HSPK 36, HsT441, I-kappa-B kinase epsilon, IKK related kinase epsilon, IKK-epsilon, IKK-i, IKKE_HUMAN, IkBKE, Inducible I kappa-B kinase, Inhibitor of kappa light polypeptide gene enhancer in B cells kinase epsilon, Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, epsilon, Inhibitor of nuclear factor kappa-B kinase subunit epsilon, JAK L, JAK2_HUMAN, JAK3 HUMAN, JAK3_HUMAN, JNK Activated Kinase 1, JNK-activating kinase 1, JNKK, JNKK-1, JTK 10, JTK7, Janus Activating Kinase 2, Janus kinase 2, Janus kinase 2 (a protein tyrosine kinase), Janus kinase 3, Janus kinase 3 (a protein tyrosine kinase, leukocyte), KIAA0151, L-JAK, Leukocyte janus kinase, M3K11_HUMAN, MAP kinase kinase 4, MAP2K4, MAPK / ERK kinase 4, MAPKK-4, MEK-4, MEKK11, MGC105683, MGC125294, MGC125295, MGC125297, MGC129910, MGC129911, MGC142877, MGC17114, MGC6593, MGC99654, MKK-4, Map3k11, Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase, Mitogen activated protein kinase kinase 4, Mitogen-activated protein kinase kinase kinase 11, Mixed lineage kinase 3, Mixed lineage protein kinase 3, Myt1 kinase, NAK, NEK3_HUMAN, NF kB activating kinase, NF-kappa-B-activating kinase, NIMA (never in mitosis gene a) related kinase 3, Never in mitosis A-related kinase 3, NimA-related protein kinase 3, OTTHUMP00000019864, OTTHUMP00000019865, OTTHUMP00000043260, OTTHUMP00000231338, OTTHUMP00000231339, P150, PCTAIRE, PCTAIRE protein kinase 1, PCTAIRE-motif protein kinase 1, PCTGAIRE, PCTK1, PLK, PLK1_HUMAN, PMYT1_HUMAN, PPP1R126, PRKMK-4, PTK1, Polo-like kinase 1, Protein kinase Myt1, Protein kinase membrane associated tyrosine/threonine 1, Protein phosphatase 1 regulatory subunit 126, Protein tyrosine kinase PTK1, Protein tyrosine kinase leukocyte, Proto oncogene tyrosine protein kinase ABL1, Proto oncogene tyrosine protein kinase YES, Proto-oncogene c-Abl, Proto-oncogene c-Yes, RHOE, Renal carcinoma antigen NY-REN-26, SAPK / ERK kinase 1, SEK 1, SERK-1, SH3 domain containing proline rich kinase, SPRK, STPK 13, Serine/threonine-protein kinase 13, Serine/threonine-protein kinase Nek3, Serine/threonine-protein kinase PCTAIRE-1, Serine/threonine-protein kinase PLK1, Serine/threonine-protein kinase TBK1, Src-homology 3 domain-containing proline-rich kinase, T2K, TANK-binding kinase 1, TBK1_HUMAN, THCYT3, Tyrosine-protein kinase ABL1, Tyrosine-protein kinase JAK2, Tyrosine-protein kinase JAK3, Tyrosine-protein kinase Yes, Tyrosine-protein kinase-defective receptor EPH-6, Uncharacterized aarF domain-containing protein kinase 1, Viral oncogene yes 1 homolog 1, WEE 1 homolog 1 (S. pombe), WEE1 homolog (S. pombe), WEE1 homolog 2 (S. pombe), WEE1 homolog S. pombe, WEE1, S. pombe, homolog of, WEE1, somatic, WEE1A, WEE1B, WEE1_HUMAN, WEE1hu, WEE2_HUMAN, Wee1 homolog, Wee1 tyrosine kinase, Wee1+ S. pombe homolog, Wee1+ homolog, Wee1-like protein kinase, Wee1-like protein kinase 1B, Wee1-like protein kinase 2, Wee1A kinase, Wee1B kinase, YES proto oncogene 1, Src family tyrosine kinase, YES1 proto oncogene, Src family tyrosine kinase, YES_HUMAN, Yamaguchi sarcoma oncogene, Yes 1, aarF domain containing kinase 1, bcr/abl, c ABL, c Yes, c abl oncogene 1 non receptor tyrosine kinase, c abl oncogene 1 receptor tyrosine kinase, c-Jun N-terminal kinase kinase 1, cdc2 inhibitory kinase, hCG_39453, kinase Jak2, p61-Yes, v abl, v abl Abelson murine leukemia viral oncogene homolog 1, v yes 1 Yamaguchi sarcoma viral oncogene homolog 1
MW 500.6 Da, Purity >98%. Potent and selective small-molecule inhibitor of Wee1 kinase. Inhibits Wee1 (IC50 = 5.2 nM) in cell-free assays. Inhibits phosphorylation of CDC2 at Tyr15 (CDC2Y15), a direct substrate of Wee1 kinase in cell-based assays. Acts synergistically with gemcitabine in tumor cells. In a panel of 223 kinases, only 8 were inhibited >80% by 1μM MK-1775.
955365-80-7
> 98%
Solid
500.6 Da
C27H32N8O2
24856436
Synthetic
Soluble in DMSO to 200 mM.
Adavosertib
Potent and selective small-molecule inhibitor of Wee1 kinase. Inhibits Wee1 (IC50 = 5.2 nM) in cell-free assays. Inhibits phosphorylation of CDC2 at Tyr15 (CDC2Y15), a direct substrate of Wee1 kinase in cell-based assays. Acts synergistically with gemcitabine in tumor cells. In a panel of 223 kinases, only 8 were inhibited >80% by 1μM MK-1775.
CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O
InChI=1S/C27H32N8O2/c1-5-13-34-25(36)21-18-28-26(29-19-9-11-20(12-10-19)33-16-14-32(4)15-17-33)31-24(21)35(34)23-8-6-7-22(30-23)27(2,3)37/h5-12,18,37H,1,13-17H2,2-4H3,(H,28,29,31)
BKWJAKQVGHWELA-UHFFFAOYSA-N
1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one
Ambient - Can Ship with Ice
-20°C
-20°C
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Chemical structure of MK-1775, 955365-80-7
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com